Paterna BioSciences is a Salt Lake City biotechnology company focused on solving male infertility through in vitro spermatogenesis (IVS). Its core technology aims to grow healthy sperm in the laboratory from a male’s own cells as a novel treatment option. The company plans to partner with IVF clinics to enhance success rates, engage men in optimizing reproductive health, and expand treatment options for IVF. Paterna intends to use recently raised capital to accelerate IVS through preclinical development, build infrastructure, and grow its team. The company raised $6M in a Seed round. Paterna expects to enter early-phase studies in 2025 and ultimately bring its solution to market following FDA approval.

Total raised

$6M

Funding rounds

1

Latest round

Seed

Latest activity

Oct 2024